top of page
Nikolai V Gourine
25 Jul 2023
Afferent Medical Solutions has successfully concluded its Phase II trial, examining the efficacy of transcutaneous vagal nerve stimulation in acute ischemic stroke patients undergoing mechanical thrombectomy.
Afferent Medical Solutions is pleased to announce the successful completion of its Phase II sham-controlled randomized trial. This trial investigated the effectiveness of autonomic modulation by transcutaneous vagal nerve stimulation in acute ischemic stroke patients requiring mechanical thrombectomy.
For media inquiries or further information, please contact:
Nikolai V Gourine
bottom of page